Evercore ISI analyst David Motemaden raised the firm’s price target on Arch Capital (ACGL) to $100 from $97 and keeps an In Line rating on the shares. With a tough cyclical backdrop, 2026 is “shaping up to be a challenging year for the P&C insurance sector,” but this presents “a stock pickers market with opportunities for discerning investors,” the analyst says in a year-ahead outlook note for the group.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACGL:
- Arch Capital price target raised to $117 from $111 at JPMorgan
- Arch Capital price target raised to $102 from $100 at Keefe Bruyette
- Arch Capital price target lowered to $131 from $135 at BofA
- Arch Capital initiated with a Neutral at Mizuho
- Arch Capital price target lowered to $110 from $125 at Roth Capital